logo
MARKED MITIGATION OF TRANSPLANT VASCULAR SCLEROSIS IN FasL gld (CD95L) MUTANT RECIPIENTS
GRAFT SURVIVAL IS IMPROVED BY HEPATIC DENERVATION BEFORE ORGAN HARVESTING1
A PILOT STUDY ON THE SAFETY AND EFFECTIVENESS OF IMMUNOSUPPRESSION WITHOUT PREDNISONE AFTER LIVER TRANSPLANTATION
AUXILIARY PARTIAL ORTHOTOPIC LIVING DONOR LIVER TRANSPLANTATION AS AN AID FOR SMALL-FOR-SIZE GRAFTS IN LARGER RECIPIENTS1,2
RENAL TRANSPLANTATION ACROSS THE ABO BARRIER USING A2 KIDNEYS
RACIAL DIFFERENCES BETWEEN SOLID ORGAN TRANSPLANT DONORS AND RECIPIENTS IN BRITISH COLUMBIA
THE USE OF AN ANTI-TCRαβ MONOCLONAL ANTIBODY TO CONTROL HOST-VERSUS-GRAFT REACTIONS IN CANINE MARROW ALLOGRAFT RECIPIENTS CONDITIONED WITH LOW DOSE TOTAL BODY IRRADIATION1
SEQUENCING OF TWO HLA-A BLANK ALLELES: IMPLICATIONS IN UNRELATED BONE MARROW DONOR MATCHING1
INHIBITION OF HUMAN DENDRITIC CELL FUNCTIONS BY METHYLPREDNISOLONE
PRESERVED LONG-TERM REPOPULATION AND DIFFERENTIATION PROPERTIES OF HEMATOPOIETIC GRAFTS SUBJECTED TO EX VIVO EXPANSION WITH STEM CELL FACTOR AND INTERLEUKIN 111
ROLE OF DONOR LEUKOCYTE CHIMERISM IN ESTABLISHING THE ETIOLOGY OF NEUTROPENIA AFTER LIVER TRANSPLANTATION1
INTERFERON-γ IS NECESSARY FOR INITIATING THE ACUTE REJECTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-DISPARATE SKIN ALLOGRAFTS1
ACQUIRED PROTEIN S DEFICIENCY WITH MULTIPLE THROMBOTIC COMPLICATIONS AFTER ORTHOTOPIC LIVER TRANSPLANT
SUCCESSFUL LIVER TRANSPLANTATION AFTER INDUCTION CHEMOTHERAPY IN CHILDREN WITH INOPERABLE, MULTIFOCAL PRIMARY HEPATIC MALIGNANCY
EPSTEIN-BARR VIRUS (EBV) ASSOCIATED B-CELL LYMPHOPROLIFERATIVE DISEASE FOLLOWING HLA IDENTICAL SIBLING MARROW TRANSPLANTATION FOR APLASTIC ANAEMIA IN A PATIENT WITH AN EBV SERONEGATIVE DONOR
FOSCARNET-INDUCED CRYSTALLINE GLOMERULONEPHRITIS WITH NEPHROTIC SYNDROME AND ACUTE RENAL FAILURE AFTER KIDNEY TRANSPLANTATION
POSTTRANSPLANTATION B LYMPHOBLASTIC LEUKEMIA WITH BURKITT-LIKE FEATURES1
MICROCHIMERISM IN SENSITIZED RENAL PATIENTS
HaNDL SYNDROME AFTER "BENIGN" OKT3-INDUCED MENINGITIS
ERRATA
ANNOUNCEMENTS